Mylan, US drug maker soon to distribute two drugs in India to treat liver diseases. Mylan Pharmaceuticals said its Indian subsidiary, Mylan Pharmaceuticals Private Limited, has received exclusive rights to distribute the branded medicines Sovaldi for liver diseases and Havaroni for chronic hepatitis C. India last month became the first country in Asia to approve Sovaldi, and distribution of the branded drug is set to begin in the second quarter this year, Mylan ...
Read More
You have just read an article categorized health
titled Mylan Soon to Distribute Hepatitis C Drugs in India.
Written by:
editor -
Monday, February 23, 2015
There are currently no comments for "Mylan Soon to Distribute Hepatitis C Drugs in India"
Post a Comment